Occurrence of non-Q wave myocardial infarction following percutaneous coronary intervention in the stent era: Systematic monitoring of the three markers of myocardial necrosis

Journal of Interventional Cardiology

Volumn 18, Issue 4, 2005, Pages 243-248

  Varani, Elisabetta ^a   Balducelli, Marco ^a   Vecchi, Giuseppe ^a   Gatti, Cinzia ^a   Riccilucchi, Giulia ^a   Maresta, Aleardo ^a,b  

^a Presidio Ospedaliero S Maria delle Croci   (Italy)

^b SANTA MARIA DELLE CROCI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; CREATINE KINASE MB; FIBRINOGEN RECEPTOR ANTAGONIST; TROPONIN I; BIOLOGICAL MARKER; ISOENZYME;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY STENT; FEMALE; HEART INFARCTION; HEART MUSCLE NECROSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; VASCULAR DISEASE; BLOOD; ELECTROCARDIOGRAPHY; HEART MUSCLE; NECROSIS; PATHOLOGY; PROSPECTIVE STUDY; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; CREATINE KINASE; CREATINE KINASE, MB FORM; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; ISOENZYMES; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; NECROSIS; PROSPECTIVE STUDIES; TROPONIN I;

EID: 27244432749     PISSN: 08964327     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2005.00042.x     Document Type: Article

References (26)

1. Califf RM, Abdelmeguid AE, Kuntz RE, et al. Myonecrosis after revascularization procedures. J Am Coll Cardiol 1998;31:241-251.
2. Klein LW, Kramer BL, Howard E, et al. Incidence and clinical significance of transient creatine kinase elevations and the diagnosis of non-Q wave myocardial infarction associated with coronary angioplasty. J Am Coll Cardiol 1991;17:621-626.
3. Kugelmass AD, Cohen DJ, Moscucci M, et al. Elevation of the creatine kinase myocardial isoform following otherwise successful directional coronary atherectomy and stenting. Am J Cardiol 1994;74:748-754.
4. Kong TQJ, Davidson CJ, Meyers SN, et al. Prognostic implication of creatine kinase elevation following elective coronary artery interventions. JAMA 1997;277:461-466.
5. Ohman E, Tardiff B, Periprocedural cardiac marker elevation after percutaneous coronary artery revascularization: Importance and implications. JAMA 1997;277:495-497.
6. Abdelmeguid AE, Topol EJ, Whitlow PL, et al. Significance of mild transient release of cretine kinase-MB fraction after percutaneous coronary interventions. Circulation 1996;94:1528-1536.
7. Kini A, Marmur JD, Kini S, et al. Creatine kinase-MB elevation after coronary intervention correlates with diffuse atherosclerosis, and low-to-medium level elevation has a benign clinical course: Implications for early discharge after coronary intervention. J Am Coll Cardiol 1999;34:663-671.
8. Stone GW, Mehran R, Dangas G, et al. Differential impact on survival of electrocardiographic Q-wave versus enzymatic myocardial infarction after percutaneous intervention: A device-specific analysis of 7147 patients. Circulation 2001;104:642-647.
9. Ottani F, Galvani M, Dolci A, et al. I marcatori di danno miocardico nella diagnosi di infarto miocardico acuto: La realtà italiana nell'anno 2000. Ital Heart J Suppl 2002;3:933-942.
10. Ghazzal Z, Ashfaq S, Morris DC, et al. Prognostic implication of creatine kinase release after elective percutaneous coronary intervention in the pre-IIb/IIIa antagonist era. Am Heart J 2003;145:1006-1012.
11. Kini AS, Lee P, Marmur JD, et al. Correlation of post-percutaneous coronary intervention creatine kinase-MB and troponin I elevation in predicting mid-term mortality. Am J Cardiol 2004;93:18-23.
12. Antman E, Bassand J-P, Klein W, et al. Myocardial infarction redefined-A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000;36:959-969.
13. Smith SC Jr, Dove JT, Jacobs AK, et al. ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines). A report of the American College of Cardiology/American Heart Association Task force on practice guidelines (Committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty). J Am Coll Cardiol 2001;37:2215-2238.
14. Kontos MC, Fritz LM, Anderson FP, et al. Impact of the troponin standard on the prevalence of acute myocardial infarction. Am Heart J 2003;146:446-152.
15. Wu AH, Apple FS, Gibler WB, et al. National Academy of Clinical Biochemistry standards of laboratory practice: Recommendations for the use of cardiac markers in coronary artery disease. Clin Chem 1999;45:1104-1121.
16. Jaffe AS, Ravkilde J, Roberts R, et al. It's time for a change to a troponin standard. Circulation 2000;102:1216-1220.
17. Panteghini M. Diagnostic application of CK-MB mass determination. Clin Chim Acta 1998;272:23-31.
18. Apple FS, Murakami M, Panteghini M, et al. International survey on the use of cardiac markers. Clin Chem 2001;47:587-588.
19. Saucedo JF, Mehran R, Dangas G, et al. Long-term clinical events following creatine kinase-myocardial band isoenzyme elevation after successful coronary stenting. J Am Coll Cardiol 2000;35:1134-1141.
20. Iakovou I, Mintz GS, Dangas G, et al. Increased CK-MB release is a "trade-off" for optimal stent implantation: An intravascular ultrasound study. J Am Coll Cardiol 2003;42:1900-1905.
21. Sharma SK, Kini A, Marmur JD, et al. Cardioprotective effect of prior beta-blocker therapy in reducing creatine kinase-MB elevation after coronary intervention. Benefit is extended to improvement in intermediate-term survival. Circulation 2000;102:166-172.
22. Serruys PW, Foley DP, Jackson G, et al. A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty: Final results of the fluvastatin angiographic restenosis (FLARE) trial. Eur Heart J 1999;20:58-69.
23. Gurm HS, Ellis SG. Periprocedural myonecrosis: From a laboratory anomaly to a sentinel of risk. Ital Heart J 2003;4:1-3.
24. Briguori C, Colombo A, Airoldi F, et al. Statin administration before percutaneous coronary intervention: Impact on periprocedural myocardial infarction. Eur Heart J 2004;25:1822-1828.
25. Ricciardi M, Wu E, Davidson C, et al. Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation. Circulation 2001;103:2780-2783.
26. Cavallini C, Savonitto S, Significato prognostico dell'elevazione degli indici di danno miocardico dopo interventi di rivascolarizzazione coronarica percutanea. Ital Heart J Suppl 2002;3:286-296.